CT Datasets Now Enable Patient Specific Endovascular Procedure Simulation

July 22, 2014 — Simbionix USA announced the signing of a collaboration agreement with Pie Medical Imaging BV. The company manufactures and distributes the 3mensio software, a clinical application that enables the visualization and analysis of patient computed tomography (CT) scans in both 2-D and 3-D modes. The collaboration will enable the exporting of the 3mensio Vascular model into the Simbionix simulation environment to form a comprehensive planning solution that combines 3DR, data analysis and simulation on the same platform.

The solution will allow physicians and clinical specialists to rehearse a procedure in a complete virtual environment without the need for physical tools. This will take users of the 3mensio software to the next level of preparedness for endovascular procedures, as it will allow added simulation insights. Cases created by the software may also be imported to the Angio Mentor simulator for full procedure practice using fluoroscopy, guidewires, catheters and other equipment that is used in the cath lab.

Simbionix’s PROcedure Rehearsal Studio (PRS) steps up simulation by enabling physicians to rehearse a complete endovascular procedure on a virtual 3-D anatomical model based on a specific patient's CT data. The virtual model can be used for simulating, analyzing and evaluating pre-operative surgical treatment options prior to performing an actual case, which may increase a physician's confidence in the upcoming procedure. Simbionix recently received CE mark for its patient specific simulation.

In addition, Simbionix PRS has recently been granted a patent in China. The company now has patents for this technology in three key countries: the U.S., U.K. and China. These patents represent recognition for Simbionix's comprehensive line of products.

Gary Zamler, Simbionix CEO, said, "Growing interest from the image analysis market, which 3mensio is part of, demonstrates the need for more comprehensive planning solutions. The ability to evaluate surgical treatment options using simulation anytime, anywhere, is a major factor in achieving the goal to increase patient safety and improve procedure outcomes. The collaboration agreement, CE mark and additional patent are all examples of the company's key position as a market leader and innovator in the field of medical simulation."

For more information: www.simbionix.com

Related Content

Feature | Radiology Business | By Melinda Taschetta-Millane

Imaging Technology News (ITN) won the National Gold Award for its PHOTO GALLERY: How COVID-19 Appears on Medical Imaging ...

Time May 13, 2022
arrow
News | Radiation Oncology

May 5, 2022 — RaySearch Laboratories AB will be showcasing the latest oncology software innovations at ESTRO 2022, to be ...

Time May 05, 2022
arrow
News | Radiology Imaging

May 5, 2022 — Significant imaging findings (cancer, infection, pseudoaneurysm, fracture, bowel perforation) can occur in ...

Time May 05, 2022
arrow
News | Cardiac Imaging

May 2, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), routine visual ordinal coronary artery calcium ...

Time May 02, 2022
arrow
News | Artificial Intelligence

April 29, 2022 — Nano-X Imaging LTD, an innovative medical imaging technology company, today announced that its deep ...

Time April 29, 2022
arrow
News | Cardiac Imaging

April 28, 2022 — Aspirin therapy, as opposed to statin use, for non-obstructive coronary artery disease does not reduce ...

Time April 28, 2022
arrow
News | Computed Tomography (CT)

April 27, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the selection of oral contrast agent and ...

Time April 27, 2022
arrow
News | Lung Imaging

April 19, 2022 — A consensus reached by a lung clinical community within the International Cancer Benchmarking ...

Time April 19, 2022
arrow
News | Computed Tomography (CT)

April 15, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), noncancerous imaging markers on chest CT ...

Time April 15, 2022
arrow
News | Lung Imaging

April 11, 2022 — Mount Sinai researchers have developed a novel method to identify aggressive early-stage lung cancers ...

Time April 11, 2022
arrow
Subscribe Now